Future Oncology

SJR Rank #3,490H-index: 102SJR: 1.229Best quartile: Q1

Journal website: aims, scope and author guidelines

Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

Subject Categories

Medicine (miscellaneous)Q1
OncologyQ1
Cancer ResearchQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Lung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Research StudiesColorectal Cancer Treatments and StudiesHER2/EGFR in Cancer ResearchProstate Cancer Treatment and ResearchGastric Cancer Management and OutcomesLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

1744-8301, 1479-6694

SJR Best Quartile

Region

Western Europe

Citations per Document (2 years)

2.61

References per Document

34.77

Coverage

2005-2026

Scope

The next few decades will see dramatic changes within the field of oncology. Whilst the burden of disease is set to increase, the available armamentarium to the oncologist will be greater, more robust and offer the potential to focus on individual needs. Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community.

Metrics from SCImago Journal Rank 2025. View on SCImago